Table 2 Comparison of Prosigna® and SiNK™ score categories (3-tiered) in the test development cohort (n = 79).

From: Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis

 

Prosigna 0–40

Prosigna 41–60

Prosigna 61–100

Total

SiNK ≤ 40

35

6

0

41

SiNK >40–60

6

9

5

20

SiNK >60

2

4

12

18

Total

43

19

17

79

  1. Score categorization concordant in 71% (56 of 79). Two step discordance: 2.5%.
Back to article page